TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32914639

Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy programme (36 one-hour sessions over 12 weeks, including 45 minutes of face-to-face therapy)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Self-care goals
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Productivity goals
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Leisure goals
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Other goals
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Goals achievement based on time post stroke
Number of subjects: 259
Study: 35523631

Group type: EXPERIMENTAL
Intervention: Active diagnostic strategy for pulmonary embolism (PE)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 175
Study: 32434291

Group type: EXPERIMENTAL
Intervention: Nebulized dexmedetomidine (1 µg/kg in 3‐4 ml of 0.9% saline)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% saline (3‐4 ml)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nebulized dexmedetomidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 120
Study: 33210977

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35065683

Group type: COMPARATOR
Intervention: High-titre RV3-BB vaccine
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Mid-titre RV3-BB vaccine
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Low-titre RV3-BB vaccine
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: High-titre RV3-BB vaccine (infant schedule)
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Overall vaccine take
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 711
Study: 33743009

Group type: EXPERIMENTAL
Intervention: Periareolar dermis release (experimental group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no periareolar dermis release)
Number of subjects: 39
Study: 33423986

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (10 mg/kg in 100 ml isotonic saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (100 ml isotonic saline)
Number of subjects: 60
Study: 35113416

Group type: EXPERIMENTAL
Intervention: Mid-forearm group (120 patients)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Wrist group (120 patients)
Number of subjects: 240
Study: 33979557

Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (BUD-FORM)
Number of subjects: 6735

Group type: COMPARATOR
Intervention: BUD maintenance
Number of subjects: 6735
Study: 34346831

Group type: EXPERIMENTAL
Intervention: Auto-regulatory progressive resistance exercise (APRE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Linear programming resistance exercise (LPRE)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both APRE and LPRE
Number of subjects: 24
Study: 32115370

Group type: EXPERIMENTAL
Intervention: PACE Steps to Success intervention
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Recommendations for implementing palliative care
Number of subjects: 39
Study: 34520052

Group type: EXPERIMENTAL
Intervention: Anti-PD-1-based first-line treatment
Number of subjects: 82
Study: 33204004

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Probiotics (under 30 days)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Probiotics (over 30 days)
Number of subjects: 44
Study: 33843477

Group type: EXPERIMENTAL
Intervention: Twin Block group (TB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bionator group (B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 30
Study: 33709771

Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises (CPE), performed two times a week for 8 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 33348180

Group type: EXPERIMENTAL
Intervention: SCL‐20
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: PHQ‐9
Number of subjects: 409
Study: 35157236

Group type: EXPERIMENTAL
Intervention: HSK3486 0.4 mg/kg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Propofol 2.0 mg/kg
Number of subjects: 267
Study: 33746195

Group type: EXPERIMENTAL
Intervention: Papilocare, a Coriolus versicolor-based vaginal gel
Number of subjects: 91

Group type: COMPARATOR
Intervention: Watchful waiting approach (control)
Number of subjects: 91
Study: 32122315

Group type: EXPERIMENTAL
Intervention: NEVERMIND system (smart shirt and mobile application)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: NEVERMIND system
Number of subjects: 330
Study: 35170523

Group type: EXPERIMENTAL
Intervention: Modified UK diagnostic tool
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Parent-reported medically diagnosed eczema
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Parent-reported use of topical corticosteroids
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Patient-Oriented Eczema Measure (POEM) scores
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: SCORing Atopic Dermatitis (SCORAD) clinical assessment
Number of subjects: 538
Study: 34847063

Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention (Click & Crunch)
Number of subjects: 2207

Group type: COMPARATOR
Intervention: Control (usual online ordering only)
Number of subjects: 2207
Study: 35551628

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange (TPE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TPE
Number of subjects: 100

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 100
Study: 32353206

Group type: EXPERIMENTAL
Intervention: Individual training (IT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group training (GT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individual training progressing to group training (IPGT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (GT only)
Number of subjects: 90
Study: 35710091

Group type: EXPERIMENTAL
Intervention: Calf muscle exercise training (ETC) in addition to compression therapy (CT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) in addition to compression therapy (CT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Compression therapy (CT) alone
Number of subjects: 32
Study: 33957371

Group type: EXPERIMENTAL
Intervention: Rasburicase 1.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rasburicase 3 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rasburicase (1.5−3 mg) with allopurinol 300 mg daily
Number of subjects: 24
Study: 32394423

Group type: EXPERIMENTAL
Intervention: Emotion dysregulation (assessed by the Difficulties in Emotion Regulation Scale - DERS)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Emotion dysregulation subscales
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Distress tolerance and intolerance of uncertainty
Number of subjects: 259
Study: 34260549

Group type: EXPERIMENTAL
Intervention: Group Rational Emotive Behavior Therapy (group REBT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study: 32213019

Group type: EXPERIMENTAL
Intervention: Antibiotics for acute and chronic pouchitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti‐tumour necrosis factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent ileostomy
Number of subjects: 0
Study: 35567829

Group type: EXPERIMENTAL
Intervention: Activity-based training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Strengthening exercises
Number of subjects: 40
Study: 33612439

Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (16 g/d)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (16 g/d)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Whey-soy blended protein supplementation (16 g/d)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (maintained habitual diets)
Number of subjects: 123
Study: 32787921

Group type: EXPERIMENTAL
Intervention: Gamified approach
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 31
Study: 36277594

Group type: EXPERIMENTAL
Intervention: Sequential ventilation therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional invasive mechanical ventilation
Number of subjects: 96
Study: 33902955

Group type: EXPERIMENTAL
Intervention: Atezolizumab 1200 mg every 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (vinflunine 320 mg/m2, paclitaxel 175 mg/m2, or docetaxel 75 mg/m2 according to investigator choice) every 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 35197538

Group type: EXPERIMENTAL
Intervention: Video-assisted discharge education (VADE) program
Number of subjects: 31

Group type: COMPARATOR
Intervention: Physiotherapy program
Number of subjects: 31
Study: 33015732

Group type: EXPERIMENTAL
Intervention: FO salmon (2 portions/week)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: RO salmon (2 portions/week)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no additional salmon)
Number of subjects: 51
Study: 34195784

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia with postoperative epidural analgesia
Number of subjects: 1712

Group type: COMPARATOR
Intervention: General anesthesia alone with postoperative intravenous analgesia
Number of subjects: 1712

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 1712

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 1712
Study: 33170240

Group type: EXPERIMENTAL
Intervention: Nicotine e‐cigarettes plus counseling
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Nonnicotine e‐cigarettes plus counseling
Number of subjects: 376

Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 376
Study: 35780458

Group type: EXPERIMENTAL
Intervention: Health care worker training intervention (SISTAQUIT) including ABCD approach, educational resource package, free oral nicotine replacement therapy, implementation support, and trial implementation training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care provided by health care providers in control group services
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Health service process evaluations; knowledge, attitudes, and practices of health care providers; longer term abstinence; perinatal outcomes; respiratory outcomes for babies (to six months)
Number of subjects: 21
Study: 32541300

Group type: EXPERIMENTAL
Intervention: Perioperative therapeutic suggestion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine perioperative care
Number of subjects: 30
Study: 32703215

Group type: EXPERIMENTAL
Intervention: Health worker knowledge of artesunate treatment policies
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Knowledge of dosing intervals
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Knowledge of preparation solutions
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Knowledge of artesunate dose for weight categories
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Knowledge of preferred route of administration
Number of subjects: 697

Group type: COMPARATOR
Intervention: Display of artesunate administration posters
Number of subjects: 697

Group type: COMPARATOR
Intervention: Paediatric ward allocation
Number of subjects: 697

Group type: COMPARATOR
Intervention: Repeated surveys
Number of subjects: 697

Group type: COMPARATOR
Intervention: Availability of artesunate at hospitals
Number of subjects: 697

Group type: COMPARATOR
Intervention: Health worker pre-service training
Number of subjects: 697

Group type: COMPARATOR
Intervention: In-service malaria case-management training
Number of subjects: 697

Group type: COMPARATOR
Intervention: Access to malaria guidelines
Number of subjects: 697
Study: 35473394

Group type: EXPERIMENTAL
Intervention: Low load working memory maintenance with distractors
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High load working memory maintenance
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low load working memory maintenance
Number of subjects: 22
Study: 33063157

Group type: EXPERIMENTAL
Intervention: Hypo group (glucose < 3.3 mmol/L)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-hypo group (glucose ≥ 3.3 mmol/L)
Number of subjects: 44
Study: 32931668

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35961347

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32030916

Group type: EXPERIMENTAL
Intervention: General stress
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Parenting distress
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Household chaos
Number of subjects: 110
Study: 36367227

Group type: EXPERIMENTAL
Intervention: Young Person's Face IT (YPF), a web‐based psychosocial intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 102
Study: 35725616

Group type: EXPERIMENTAL
Intervention: Rehabilitation Gaming System (RGS) combined with standard care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 90
Study: 32199548

Group type: EXPERIMENTAL
Intervention: Individual counseling
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 12-Step participation
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Individual counseling and 12-Step participation interaction
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Participant age
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Group therapy
Number of subjects: 570
Study: 35108175

Group type: EXPERIMENTAL
Intervention: Temporary transvenous diaphragm neurostimulation (treatment)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 112
Study: 33753882

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 100
Study: 32161036

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34266934

Group type: EXPERIMENTAL
Intervention: activL
Number of subjects: 283

Group type: COMPARATOR
Intervention: ProDisc-L
Number of subjects: 283
Study: 35348880

Group type: EXPERIMENTAL
Intervention: Educational intervention (20 min oral presentation based on literature and international guidelines)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 60
Study: 33741648

Group type: EXPERIMENTAL
Intervention: 68Ga-THP PSMA PET/CT
Number of subjects: 49
Study: 32818953

Group type: EXPERIMENTAL
Intervention: Sensory substitution device
Number of subjects: 7

Group type: COMPARATOR
Intervention: White cane
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination of both (sensory substitution device and white cane)
Number of subjects: 7
Study: 35321960

Group type: EXPERIMENTAL
Intervention: Ceramic femoral head with HXPLE insert
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Ceramic femoral head 40mm
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Ceramic femoral head 44mm
Number of subjects: 143
Study: 33988528

Group type: EXPERIMENTAL
Intervention: Posteromedial quadratus lumborum block
Number of subjects: 116

Group type: COMPARATOR
Intervention: Wound infiltration
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 116
Study: 32631301

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with parecoxib sodium (group DP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Parecoxib sodium (group P)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 120
Study: 35504795

Group type: EXPERIMENTAL
Intervention: Seating intervention by experts in addition to conventional rehabilitation (Group 2)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional rehabilitation (Group 1)
Number of subjects: 19
Study: 35420589

Group type: EXPERIMENTAL
Intervention: TAU + app-based MT
Number of subjects: 80

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 80
Study: 33905530

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus radiation therapy (RT)
Number of subjects: 1463

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 1463
Study: 36026532

Group type: EXPERIMENTAL
Intervention: Multicomponent de-frailing intervention (exercise, cognitive stimulation, protein supplementation, iron replacement)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 135
Study: 34444980

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 (PS128)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35971210

Group type: EXPERIMENTAL
Intervention: In-person contact only and both phone and in-person contact
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Retention analysis
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Average number of GVs attended
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: GV attendance
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Self-reported motivating factors
Number of subjects: 75
Study: 33674675

Group type: EXPERIMENTAL
Intervention: Robot-assisted rehabilitation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study: 34275765

Group type: EXPERIMENTAL
Intervention: Tart Cherry (TC) concentrate (50 tart cherries), 1 Oz in 8 Oz water daily for 6 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (syrup)
Number of subjects: 48
Study: 33639391

Group type: EXPERIMENTAL
Intervention: Nicotine patches (received at baseline)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Additional NRT purchase
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Interest in free-of-charge NRT
Number of subjects: 999
Study: 35655647

Group type: EXPERIMENTAL
Intervention: Jodhpur technique (JT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Split-thickness skin grafting (STSG)
Number of subjects: 32
Study: 32998924

Group type: EXPERIMENTAL
Intervention: Topical chlorhexidine 0.2%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical natamycin 5%
Number of subjects: 0
Study: 33917778

Group type: EXPERIMENTAL
Intervention: Measured Resting Metabolic Rate (mRMR) dietary intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Estimated Resting Metabolic Rate (eRMR) dietary intervention
Number of subjects: 54
Study: 35152940

Group type: EXPERIMENTAL
Intervention: Moulded cast (n=255)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Surgical fixation with K-wires (n=245)
Number of subjects: 500
Study: 34628741

Group type: EXPERIMENTAL
Intervention: Acupuncture and rehabilitation training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rehabilitation training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cerebral palsy group
Number of subjects: 20
Study: 35222018

Group type: EXPERIMENTAL
Intervention: Pharmacist-led self-care education (two face-to-face educational sessions at enrollment and on week 12)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study: 34872271

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SPB)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous serratus anterior plane block (CSPB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 120
Study: 36348276

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (60 mg/day)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 36400384

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (nCT) followed by minimally invasive esophagectomy (MIE)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (nCT)
Number of subjects: 264
Study: 34614123

Group type: EXPERIMENTAL
Intervention: injectable platelet-rich fibrin (i-PRF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: methylprednisolone acetate (corticosteroids)
Number of subjects: 24
Study: 34935935

Group type: EXPERIMENTAL
Intervention: Hypoxia (simulated high altitude at 4200 m)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normoxia (sea-level conditions)
Number of subjects: 7
Study: 33252671

Group type: EXPERIMENTAL
Intervention: Hospital Consultation (HC)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Usual Hospital Care (UHC)
Number of subjects: 342
Study: 35834380

Group type: EXPERIMENTAL
Intervention: Rigid thoracolumbar orthosis (Boston brace)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Elastic lumbar support
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study: 34169174

Group type: EXPERIMENTAL
Intervention: Tailored video vignettes
Number of subjects: 1393

Group type: COMPARATOR
Intervention: General clinical trials education (text)
Number of subjects: 1393
Study: 35152152

Group type: EXPERIMENTAL
Intervention: Intravenous nafamostat (0.2 mg/kg/h for a maximum of seven days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intravenous nafamostat
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 42
Study: 34051911

Group type: EXPERIMENTAL
Intervention: Classroom Strategies Coaching Model (CSC)
Number of subjects: 2195

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 2195
Study: 35435843

Group type: EXPERIMENTAL
Intervention: Alcohol septal ablation
Number of subjects: 134
Study: 32187789

Group type: COMPARATOR
Intervention: Biomedical-focused education and exercise therapy
Number of subjects: 64